Research-grade peptides with COA on every order. Browse the full SelaraLabs catalog.

BPC-157 is a synthetic pentadecapeptide derived from a protective gastric protein. Preclinical research demonstrates accelerated tendon-to-bone healing, angiogenesis promotion, and cytoprotective effects across multiple tissue types.

GHK-Cu is a naturally occurring copper-binding tripeptide with demonstrated roles in skin remodeling, collagen synthesis, and antioxidant defense. Research reveals broad gene expression modulation affecting over 4,000 human genes linked to anti-inflammatory and tissue-repair pathways.

GLOW is a proprietary peptide complex targeting dermal fibroblast activation and epidermal barrier restoration. Research models demonstrate enhanced hyaluronic acid synthesis, increased collagen type I deposition, and measurable reduction in oxidative damage markers in skin tissue.

Tirzepatide is a dual GIP/GLP-1 receptor agonist demonstrating superior weight reduction compared to GLP-1 mono-agonists in preclinical and clinical research. It activates both incretin pathways, producing complementary effects on appetite suppression and insulin secretion.

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, demonstrating significant adipose tissue reduction in preclinical models. Research indicates enhanced metabolic flexibility and improved lipid profiles compared to single-receptor agonists.

KLOW is a bioregulatory peptide demonstrating modulation of cellular senescence pathways and mitochondrial biogenesis. Preclinical models indicate improved markers of biological age and enhanced tissue regenerative capacity through NAD+ pathway activation.

MOTS-C is a mitochondria-derived peptide that regulates metabolic homeostasis by activating AMPK signaling. Preclinical research demonstrates improved insulin sensitivity, increased fatty acid oxidation, and enhanced exercise capacity in rodent models.

SELANK is a synthetic heptapeptide analogue of tuftsin with anxiolytic and nootropic properties. Research demonstrates modulation of GABA-A receptor activity, upregulation of BDNF expression, and stabilization of enkephalins — supporting cognitive performance and stress resilience.

SS-31 (Elamipretide) is a mitochondria-targeted antioxidant peptide that selectively concentrates at the inner mitochondrial membrane. Research demonstrates restoration of mitochondrial cristae architecture, reduction of ROS production, and improved bioenergetic efficiency in aging and disease models.

Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH) that stimulates endogenous GH secretion in a pulsatile, physiological manner. Research demonstrates marked visceral adipose tissue reduction and favorable effects on IGF-1 levels.